飩� Process development to improve the production of therapeutically valuable proteins and monoclonal antibodies expressed in CHO cell lines (suspension cell culture) and E. coli via recombinant DNA technology.
飩� Process development, in process testing, scale-up and technology transfer to production, material generation for toxicology, clinical trials and dossier preparation (RCGM, PTD, TTD).
飩� Created technology for scale up/down model for microbial and cell culture based on hydrodynamic and geometric similarities as a function of process parameters at 2L to 500L bioreactor.
飩� Provide Technical and Strategic Leadership responsible for delivering Bio-similar pipeline.
飩� Multidisci
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
